Boston Scientific Indefinite-Lived Intangible Assets remained flat by 0.0% to $813.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 764.9%, from $94.00M to $813.00M. Over 4 years (FY 2020 to FY 2024), Indefinite-Lived Intangible Assets shows a downward trend with a -29.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Stability or growth indicates the sustained value of the company's brand or core intellectual property.
These are intangible assets, such as brand names or certain licenses, that are expected to provide value for an unlimite...
Standard for companies with strong brand equity or long-term regulatory licenses.
indefinite_lived_intangible_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $330.00M | $374.00M | $246.00M | $246.00M | $232.00M | $232.00M | $232.00M | $232.00M | $174.00M | $174.00M | $174.00M | $174.00M | $214.00M | $94.00M | $94.00M | $94.00M | $813.00M | $813.00M |
| QoQ Change | — | +13.3% | -34.2% | +0.0% | -5.7% | +0.0% | +0.0% | +0.0% | -25.0% | +0.0% | +0.0% | +0.0% | +23.0% | -56.1% | +0.0% | +0.0% | +764.9% | +0.0% |
| YoY Change | — | — | — | — | -29.7% | -38.0% | -5.7% | -5.7% | -25.0% | -25.0% | -25.0% | -25.0% | +23.0% | -46.0% | -46.0% | -46.0% | +279.9% | +764.9% |